360 MD Austin
Austin, TX
Physician credentials on file
§ — Substance profile
Cathelicidin antimicrobial peptide · Human cathelicidin antimicrobial peptide
01 — Regulatory status
Regulatory status · United States · as of October 2026
Not FDA-approved. Removed from 503A Category 2 on April 15, 2026, and scheduled for review by the advisory committee before the end of February 2027. It is not on the 503A Bulks List.
Source: FDA 503A Bulks List · PCAC meeting records · verified October 2026
Reviewed October 2026 · Sources: FDA, EMA
02 — Researched for
Chronic wound infection, biofilm disruption, venous leg ulcers.
03 — What the evidence shows
A phase 2 trial of topical LL-37 in venous leg ulcers showed improved healing at lower doses. Systemic use has no controlled human data.
04 — What is claimed but not shown
Systemic antimicrobial or anti-inflammatory benefit by injection; Lyme disease treatment.
05 — Known risks
Pro-inflammatory and cytotoxic at higher concentrations; implicated in psoriasis and rosacea pathology; injection use unstudied.
06 — Researched for these goals
07 — Questions for your physician
Every practice in the registry that lists peptide therapy, sorted by distance and nothing else. You contact the practice directly.
Austin, TX
Physician credentials on file
La Jolla, CA
No physician listed on the practice website
Chandler, AZ
Physician credentials on file
Alpharetta, GA
Physician credentials on file
San Francisco, CA
Ahvie Herskowitz, MD · Ann Lee, MD
Steamboat Springs, CO
Physician credentials on file
Listed for transparency, not as an endorsement of any practice, substance or protocol. Most peptides are not FDA-approved for the uses they are offered for.
Reviewed October 2026 · Sources: FDA, EMA
This page reports on the state of research and regulation for orientation. It is not medical advice, not a recommendation for or against any substance, and not an offer. Regulatory status changes; the date shown is the date of our last verification. Discuss any treatment with a licensed physician.